Track 1

The results of a Computational model-informed comparative evaluation of Botulinum Toxin formulations. Does this model demonstrate the reason for the variable potency between "Units" of commercially available Toxins?

Speaker(s)

• 

  John H. Joseph, MD

  Director
  Clinical Testing of Beverly Hills